Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes Article

Hall, William A, Pugh, Stephanie L, Wefel, Jeffrey S et al. (2019). Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes . NEUROSURGERY, 84(1), 66-76. 10.1093/neuros/nyy003

Open Access

cited authors

  • Hall, William A; Pugh, Stephanie L; Wefel, Jeffrey S; Armstrong, Terri S; Gilbert, Mark R; Brachman, David G; Werner-Wasik, Maria; Wendland, Merideth M; Brown, Paul D; Chao, Samuel T; Roof, Kevin S; Robins, H Ian; Mehta, Minesh P; Curran, Walter J; Movsas, Benjamin

sustainable development goals

authors

publication date

  • January 1, 2019

webpage

published in

keywords

  • ADJUVANT TEMOZOLOMIDE
  • BEVACIZUMAB
  • Bevacizumab and GBM
  • Clinical Neurology
  • EXTENT
  • Extent of resection in GBM
  • Glioblastoma and extent of resection
  • Glioblastoma and radiation therapy
  • Glioblastoma and surgical resection
  • Glioblastoma resection
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • PRIMARY BRAIN
  • QUALITY-OF-LIFE
  • Quality of life GBM
  • Resection extent and neurocognitive function
  • Resection status and quality of life
  • SURVIVAL
  • Science & Technology
  • Surgery
  • THERAPY
  • TRIALS
  • VALIDATION
  • patient reported outcomes GBM

Location

  • San Antonio, TX

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 66

end page

  • 76

volume

  • 84

issue

  • 1